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that are mediated in part through alterations in glucosylcera-Glycosphingolipids modulate renal phosphate transport in po-
mide content and membrane lipid dynamics.tassium deficiency.
Background. Potassium (K) deficiency (KD) and/or hypo-
kalemia have been associated with disturbances of phosphate
metabolism. The purpose of the present study was to determine
Hypokalemia and/or potassium deficiency (KD) mod-the cellular mechanisms that mediate the impairment of renal
ulate a number of renal functional parameters includingproximal tubular Na/Pi cotransport in a model of K deficiency
renal blood flow [1], glomerular filtration rate [2], proxi-in the rat.
Methods. K deficiency in the rat was achieved by feeding rats mal tubular Na/H exchange [3], Na/citrate [4], and Na/
a K-deficient diet for seven days, which resulted in a marked sulfate [5] cotransport activities.
decrease in serum and tissue K content.
Hypokalemia and/or KD have also been shown to beResults. K deficiency resulted in a marked increase in urinary
associated with hypophosphatemia and/or an increase inPi excretion and a decrease in the Vmax of brush-border mem-
urinary phosphate excretion [6–21]. The cellular mecha-brane (BBM) Na/Pi cotransport activity (1943  95 in control
vs. 1184 99 pmol/5 sec/mg BBM protein in K deficiency, P nisms showing how hypokalemia or KD regulates renal
0.02). Surprisingly, the decrease in Na/Pi cotransport activity was phosphate transport, however, have not been studied.
associated with increases in the abundance of type I (NaPi-1), The purpose of our study was to determine whether KDand type II (NaPi-2) and type III (Glvr-1) Na/Pi protein. The
in the rat alters proximal tubular brush-border mem-decrease in Na/Pi transport was associated with significant al-
brane (BBM) Na/Pi cotransport activity, and whetherterations in BBM lipid composition, including increases in sphin-
gomyelin, glucosylceramide, and ganglioside GM3 content and the regulation takes place at the level of the proximal
a decrease in BBM lipid fluidity. Inhibition of glucosylceramide tubular BBM Na/Pi cotransport system.
synthesis resulted in increases in BBM Na/Pi cotransport activ- Our results indicate that KD causes a significant in-ity in control and K-deficient rats. The resultant Na/Pi cotrans-
crease in the urinary excretion of Pi and a parallel de-port activity in K-deficient rats was the same as in control rats
crease in the Vmax of BBM Na/Pi cotransport activity.(1148  52 in control  PDMP vs. 1152  61 pmol/5 sec/mg
BBM protein in K deficiency  PDMP). These changes in Surprisingly, the decrease in Na/Pi cotransport activity
transport activity occurred independent of further changes in occurred despite an increase in the level of BBM type
BBM NaPi-2 protein or renal cortical NaPi-2 mRNA abundance. II Na/Pi cotransport protein (NaPi-2) and no changeConclusion. K deficiency in the rat causes inhibition of renal
in cortical NaPi-2 mRNA abundance. In addition, theNa/Pi cotransport activity by post-translational mechanisms
abundance of type I Na/Pi cotransport protein (NaPi-1)
and type III Na/Pi cotransport protein (Glvr-1) was also
1 Dr. Zajicek and Dr. Wang contributed equally to this work. increased. The decrease in BBM Na/Pi cotransport activ-
ity was associated with significant increases in BBM
Key words: Na/Pi cotransport proteins, lipid fluidity, membrane lipid
sphingomyelin, glucosylceramide and ganglioside GM3dynamics, hypokalemia, glucosylceramide, ganglioside GM3, brush-
border membrane, proximal tubule. content, and a decrease in BBM lipid fluidity. Inhibition
of glucosylceramide synthesis resulted in a significantReceived for publication December 12, 2000
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sults therefore indicate that hypokalemia inhibits Na/Pi homogenate by differential centrifugation and Mg2 pre-
cipitation, as previously described [25, 26]. To minimizecotransport activity by post-translational mechanisms
that are mediated in part by an increase in glucosylcera- the potential day-to-day variations in the BBM isolation
procedure on the resultant measurements, each day BBMmide content.
from control and K-deficient rats were isolated simulta-
neously. For each BBM sample, the kidneys from two
METHODS
rats from each experimental group were pooled (N 
Experimental animals 1). A total of 24 rats were studied in each group, resulting
in N  12 BBM samples for each experimental group.The experiments were performed in male Sprague-
Dawley rats weighing 150 to 200 g (Harlan Industries, The final BBM pellet was resuspended in a 300 mmol/L
mannitol, 16 mmol/L HEPES, 10 mmol/L Tris, pH 7.50,Indianapolis, IN, USA). Prior to study, the animals were
stabilized on a control diet for five days in metabolic buffer and was aliquoted for simultaneous measurements
of (1) enzyme activity, (2) transport activity, (3) proteinbalance cages. The rats were then pair-fed a control or
a K-deficient diet as previously described [4, 5]. On the electrophoresis and Western blotting, (4) lipid composi-
tion, and (5) lipid fluidity.seventh day, a 24-hour urine collection was obtained. On
the eighth day, the rats were anesthetized with sodium
Brush-border membrane enzyme activity measurementspentobarbital. Blood was obtained from the inferior vena
cava, and the kidneys rapidly removed and placed in an The purity of each BBM preparation was determined
by measurement of membrane-bound specific enzyme ac-ice-cold buffer. Blood and urine samples were analyzed
for inorganic phosphate by the method of Fiske and tivity, including leucine amino peptidase (apical marker)
and Na,K-ATPase (basolateral marker) in cortical ho-Subbarow and for creatinine by a creatinine autoana-
lyzer (Creatinine II Analyzer; Beckman, Fullerton, CA, mogenate and in BBM fractions as previously described
[26]. Enzyme activities were expressed as mol/h/mgUSA) [22]. Total urinary phosphate excretion and tubu-
lar reabsorption of phosphate were calculated by stan- cortical homogenate or BBM protein. Enrichment (spe-
cific activity in BBM/specific activity in homogenate) anddard clearance formulae.
In experiments designed to determine the role of alter- recovery (total activity in BBM/total activity in homoge-
nate) were determined using the previously mentionedation in glucosylceramide content per se in the regulation
of Na/Pi cotransport (Results section), rats fed a control enzymes as markers of apical and basolateral mem-
branes. Protein was determined by the method of Lowryor K-deficient diet were also treated with DL-threo-1-phe-
nyl-2-decanoylamino-3-morpholino-1-propanol (PDMP), et al using crystalline BSA as standard [27].
an inhibitor of glucosylceramide synthase [23, 24]. Since
Brush-border membrane transport measurementsprevious studies have demonstrated that the circulating
plasma levels of PDMP are prolonged in the presence Transport measurements were performed in freshly
isolated BBM vesicles by radiotracer uptake followed byof the cytochrome P450 inhibitor, piperonyl butoxide
[23], the butoxide solution was administered before in- rapid millipore filtration. To measure the Na gradient-
dependent 32Pi uptake (Na-Pi cotransport), 10L of BBMjection of PDMP. The piperonyl butoxide was prepared
by dissolution in corn oil at a concentration of 150 preloaded in an intravesicular buffer of 300 mmol/L man-
nitol, 16 mmol/L HEPES, 10 mmol/L Tris buffer, pHmg/mL. On the first day of treatment, the butoxide solu-
tion was administered intraperitoneally four hours be- 7.50, was vortex-mixed at 25C with 40 L of an extra-
vesicular uptake buffer of 150 mmol/L NaCl, 100 mol/Lfore PDMP treatment; on days 2 to 7 of treatment, it
was administered just before the PDMP injection. PDMP K2H32PO4, 16 mmol/L HEPES, 10 mmol/L Tris, pH 7.50.
Uptake after five seconds (representing initial linearwas prepared as an emulsion with the detergent Myrj 52
in normal saline, buffered with sodium acetate. The final rate) was terminated by an ice-cold stop solution con-
sisting of 135 mmol/L NaCl, 10 mmol/L Na2 arsenate, 16concentrations were PDMP 6 mg/dL, Myrj 52 12 mg/dL,
and sodium acetate 8 mg/dL. The PDMP was given intra- mmol/L HEPES, and 10 mmol/L Tris buffer, pH 7.50.
All uptake measurements were performed in triplicate,peritoneally as a dose of 100 mg/kg body weight.
and uptake was calculated on the basis of specific activity
Brush-border membrane isolation determined in each experiment and expressed as pmol
32Pi/5 sec/mg BBM protein.The kidneys were placed in an ice-cold homogenizing
buffer consisting of 300 mmol/L mannitol, 5 mmol/L eg- To determine whether the differences in Na-Pi co-
transport were specific for Pi, Na gradient-dependenttazic acid (EGTA), 1 mmol/L phenylmethylsulfonyl flu-
oride (PMSF), 16 mmol/L HEPES, pH 7.50, with Tris glucose and proline uptake were also measured. BBM
vesicles were preloaded with the 300 mmol/L mannitol,buffer. Thin slices were cut from the superficial cortex
and homogenized with a Polytron homogenizer. Brush- 10 mmol/L HEPES, 10 mmol/L Tris (pH 7.50) intravesi-
cular buffer, and the uptake solution consisted of 150border membrane vesicles were isolated from the resulting
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mmol/L NaCl and either 100 mol/L D-[3H] glucose, or acetic acid. The resultant mixture was centrifuged for
five minutes at 800  g. The upper layer was removed.100 mol/L L-[3H] proline and HEPES-Tris, pH 7.50.
Uptake was terminated by the stop solution, which con- The lower layer was washed with 1 mL of methanol plus
0.8 mL of water. After the same centrifugation, the lowersisted of 150 mmol/L NaCl, 0.25 mol/L phloridzin, and
16 mmol/L HEPES, 10 mmol/L Tris, pH 7.50. layer was transferred into another glass tube and dried
under a stream of nitrogen gas. The lipids were then
Brush-border membrane SDS-gel protein chromatographed on high-performance thin-layer chro-
electrophoresis and Western blotting matography plates (HPTLC; E. Merck 5641). Glucosylc-
eramide and ganglioside GM3 were separated with aBrush-border membranes were denatured for two
minutes at 95C in 2% sodium dodecyl sulfate (SDS), solvent system consisting of chloroform:methanol:water
(65:25:4) on plates which were pretreated with 2.5%10% glycerol, 0.5 mmol/L ethylenediaminetetraacetic
acid (EDTA), and 95 mmol/L Tris-HCl, pH 6.8 (final borax in methanol:water (1:1). The lipid bands were visu-
alized by impregnating the plates with a modified char-concentrations). Ten micrograms of BBM protein/lane
ring reagent (100 g of CuSO45H2O in concentratedwere separated on 9% polyacrylamide gels according to
H3PO4:water:methanol (100:750:400) [23, 24]. The charredthe method of Laemmli [28] and were electrotransferred
thin-layer chromatography plates were scanned with aonto nitrocellulose membrane [29]. After blockage with
video densitometer. Comparing the density of each spot5% fat-free milk powder with 1% Triton X-100 in Tris-
with the density of the corresponding standard curvebuffered saline (TBS; 20 mmol/L, pH 7.3), Western blots
quantitated the glucosylceramide and ganglioside GM3were performed with antiserum against the C-terminal
bands.amino acid sequence of NaPi-2, NaPi-1, or Glvr-1 at a
dilution of 1:5,000. Primary antibody was visualized using
Brush-border membrane lipid fluidity measurementsenhanced chemiluminescence (ECL; Pierce, Bradford,
Brush-border membrane fluidity was determined byIL, USA). The signals were quantitated in a Phosphor
the fluorescence measurements of (1) 1,6-diphenyl-1, 3,Imager with chemiluminescence detector and densitom-
5-hexatriene (DPH) and (2) 6-dodecanoyl-2-diethyl-etry software (Bio-Rad, Richmond, CA, USA).
aminonaphthalene (Laurdan; Molecular Probes, Eugene,
Brush-border membrane lipid composition measurement OR, USA). The steady-state emission spectra of Laur-
dan were measured in a spectrofluorometer (PC1, ISS,Lipids from BBM were extracted by the method of Bligh
Champaign-Urbana, IL, USA). Excitation wavelengthand Dyer [30], as we have previously described [24, 26].
was 340 nm, and emission was measured at 440 and 490First, to determine free cholesterol content, an aliquot
nm. In phospholipid vesicles and in BBM the emissionof the lipid extract was injected into a 530 m 50% phenyl
maximum for Laurdan is 440 nm in the gel phase and 490methyl silicone column in a Hewlett-Packard model 5890
nm in the liquid-crystalline phase [35–37]. The emissiongas chromatograph with a flame ionization detector, run
spectra of Laurdan are quantitated by the generalizedisothermally at 280C, with coprostanol serving as an
polarization (GP)internal standard. Area ratios were computed with a Hew-
lett-Packard 3392A integrator, and cholesterol was ex-
GPLaurdan 
I440  I490
I440  I490
pressed as nmol/mg BBM protein [26, 31, 32].
Second, to determine individual phospholipid polar
where I440 and I490 are the emission intensities at 440 nmhead-group species, an aliquot of the lipid extract was
and 490 nm, respectively [35–37].applied to thin-layer chromatography plates (Silica Gel
The steady-state anisotropy of DPH (rDPH) was mea-60; E. Merck, Darmstadt, Germany) and individual phos-
sured in the same spectrofluorometer equipped with ex-pholipids, including sphingomyelin, phosphatidylcholine,
citation and emission polarizers. Excitation wavelengthphosphatidylethanolamine, phosphatidylserine, and phos-
was 360 nm and emission was viewed through a KV 399phatidylinositol, were separated by a two-dimensional sol-
nm filter [31, 32]. rDPH is determined byvent system [33], as we have previously described [24, 26].
Phospholipid content in total and individual phospholip-
rDPH 
III  II
III  2II
ids was determined by measuring phosphorus content
by the method of Ames and Dubin [34].
Third, to determine the glycosphingolipid composi- where III and II represent the intensities of the parallel
tion, an aliquot of the lipid extract was evaporated to and perpendicular components of the emission respec-
dryness and subjected to alkaline methanolysis. Briefly, tively [31, 32].
the dried lipids were dissolved in 2 mL of chloroform.
RNA isolationThe reaction was started by adding 1 mL of 0.21 N
sodium hydroxide:methanol, was continued for one hour Thin slices were cut at 4C from the superficial cortex
and homogenized with Polytron in a 4 mol/L guanidiumat 37C, and terminated by adding 0.8 mL of 0.2 mol/L
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Table 1. Chronic potassiuim deficiency effects after seven daysthiocyanate, 25 m mol/L sodium citrate, pH 7.0, 0.5%
sarcosyl, 0.1 mol/L 2-mercaptoethanol denaturation so- Control K deficiency P value
lution. Sequentially, 0.1 volume 2 mol/L sodium acetate, 24-hour urinary Pi excretion
mg/24 h 21.62.8 32.81.3 0.01pH 4.0, 1 volume water-saturated phenol, 0.2 volumes
BBM Na/Pi cotransport activitychloroform-isoamyl alcohol mixture (49:1) were added
pmol/5 s/mg protein 64651 46037 0.02
to the homogenate. Total RNA was isolated as pre- BBM NaPi-2 protein abundance
densitometry units 3.50.3 10.31.2 0.001viously described [38] and resuspended in water treated
Renal cortical NaPi-2/18S mRNAwith diethyl pyrocarbonate (DEPC). Absorbency at 260
abundance densitometry units 1.060.14 0.920.06 NS
and 280 nm was obtained to quantify and assess the BBM NaPi-1 protein abundance
densitometry units 3.60.1 9.82.1 0.001purity of the RNA fraction.
Renal cortical Glvr-1 protein
abundance densitometry units 5.70.4 10.90.7 0.001Formaldehyde agarose gel electrophoresis and
BBM is brush-border membrane.Northern blot analysis
Following denaturation of RNA samples in formalde-
hyde, 20 g total RNA per lane were size fractionated
using 0.66 mol/L formaldehyde, 1% agarose (final con- injected into Xenopus laevis oocytes as described previ-
ously [5]. Oocyte transport measurements were performedcentration) gels (Bio-Rad). RNA size standards (GIBCO
BRL, Gaithersburg, MD, USA) were run in parallel. using K2H32PO4 (30 Ci/mL) with 0.1 mmol/L K2HPO4, or
K2 35SO42 (30 Ci/mL) with 0.1 mmol/L K2SO4, or L-[3H]After electrophoresis the gel was placed onto a vacuum-
blotting device (Bio-Rad) and vacuum of 60 cm H2O leucine (20 Ci/mL) with 0.1 mmol/L L-leucine, as de-
scribed previously [5].was applied for four hours using 20  SSC (3 mol/L
NaCl, 0.3 mol/L Na3 citrate, pH 7.0) as a blotting buffer,
Immunofluorescence microscopywhich resulted in the complete transfer of RNA. The
RNA was blotted onto GeneScreen Plus nylon mem- For these studies, six additional control and K-defi-
cient rats were anesthetized with thiopental (Penthotal,branes (NEN/Dupont, Boston, MA, USA) and the RNA
was immobilized by irradiation with ultraviolet (UV) 100 mg/kg body weight) and perfused retrogradely at a
pressure of 1.38 hp through the abdominal aorta. Thelight (UV crosslinker; Bio-Rad). Prehybridization (4 hours
at 42C) and hybridization (18 hours at 42C) of the fixative consisted of 3% paraformaldehyde and 0.05%
picric acid, in a 6:4 mixture of cacodylate buffer (pH 7.4,RNA blots were performed with a buffer (250 L/cm2)
consisting of 5  SSPE (0.75 mol/L NaCl, 50 mmol/L adjusted to 300 mOsm with sucrose) and 10% hydroxy-
ethyl starch. After five minutes of fixation, the rats wereNaH2PO4, 5 mmol/L EDTA, pH 7.40), 5  Denhardt’s
solution [0.1% Ficoll 400, 0.1% polyvinylpyrrolidone, perfused for an additional five minutes with the cacodyl-
ate buffer [40, 44, 45]. Coronal slices of fixed kidneys0.1% BSA (fraction V)], 0.1% SDS, 100 g/mL dena-
tured salmon sperm DNA, and 50% deionized formamide were snap frozen in liquid propane cooled by liquid nitro-
gen. Sections 3m thick were cut at22C in the cryomi-as previously described [24, 39, 40]. cDNA probes of
NaPi-2 [41], GAPDH [42], and 18S [43], all full length, crotome, mounted on chromalum/gelatin-coated glass
slides, thawed, and stored in cold PBS buffer until use.were labeled by random priming (Pharmacia) using [	-32P]
dCTP (NEN/DuPont). After hybridization, each blot For NaPi-2 immunofluorescence staining, sections
were preincubated for five minutes at room temperaturewas washed twice for 15 minutes in 2  SSPE, 0.1%
SDS at room temperature, twice for 15 minutes in 0.1  with 3% milk powder in PBS containing 0.05% Triton
X-100. They were then covered overnight at 4C withSSPE, 0.1% SDS at 37C, and twice for 15 minutes in
0.1  SSPE, 0.1% SDS at 50C. Autoradiography was the NaPi-2 antibody diluted 1:500 in the preincubation
solution. The sections were rinsed three times with PBSperformed at 70C with NEN/DuPont Reflection film
using a DuPont intensifying screen (NEN/DuPont). Mem- prior to incubation for one hour at 4C with the second-
ary antibody, swine anti-rabbit IgG conjugated to FITCbranes were stripped (0.1  SSC, 0.1% SDS at 95C for
5 minutes) before another hybridization was performed. (Dakopatts, Glostrup, Denmark). The actin microfila-
ments were stained directly with rhodamine-labeled pha-mRNA levels for NaPi-2 was quantitated by a Phosphor
Imager (Bio-Rad) and the accompanying densitometry lloidin (Molecular Probes).
After rinsing with PBS the sections were mounted usingsoftware and normalized to the density of the corre-
sponding GAPDH or 18S bands. DAKO-Glycergel (Dakopatts, Glostrup, Denmark)
plus 2.5% 1,4-diazabicyclo- [2.2.2]-octane (DABCO;
Isolation of poly A RNA, injection into Sigma, St. Louis, MO, USA) as a fading retardant. They
Xenopus laevis oocytes and uptake measurements were then imaged with a laser scanning microscope
(Zeiss LSM 410; Zeiss, Jena, Germany) by confocal flu-Rat renal cortical poly A RNA (mRNA) was purified
through an oligo dT column, and mRNA (0.2 g/L) was orescence imaging.
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Fig. 1. Effect of K deficiency on kinetics of
brush-border membrane Na/Pi cotransport
activity. K deficiency caused a significant de-
crease in the Vmax of Na/Pi cotransport, while
there were no changes in the Km for Pi or Na
(data not shown). Symbols are: () control;
() potassium deficiency (KD).
Data analysis cotransport protein (NaPi-2) abundance. Western blot-
ting of BBM proteins with a polyclonal antibody againstThe data are expressed as the mean SE. The statistical
the NaPi-2 protein actually showed a marked increasesignificance of the results between samples obtained from
in BBM NaPi-2 protein abundance (Table 1). Althoughcontrol or K deficient rats was determined by the unpaired
an equal amount of BBM protein was loaded, 10 gStudent t test or one-way analysis of variance with the
BBM protein per lane, the blots for 
-actin also wereStudent–Newman–Keuls analysis for multiple compari-
probed; there was no difference in the BBM 
-actin abun-sons. Significance was accepted at the P less than 0.05.
dance in control versus KD (results not shown). In con-
trast, when the BBM proteins were probed with an anti-
RESULTS body against the sodium-sulfate cotransporter NaSi-1,
Effects of chronic potassium deficiency on urinary Pi the abundance of NaSi-1 protein decreased in parallel
excretion and BBM Na/Pi cotransport activity with the decrease in Na/Si cotransport activity in BBM
isolated from K-deficient rats. In K-deficient rats an in-Chronic K depletion of seven days’ duration caused a
crease in proximal tubular apical membrane NaPi-2 pro-significant increase in the urinary excretion of Pi (Table 1).
tein expression was also seen by immunofluorescenceThe increase in the urinary excretion of Pi was associated
microscopy (Fig. 2). The NaPi-2 protein colocalized withwith a significant decrease in BBM Na/Pi cotransport
actin, which indeed confirms BBM localization and in-activity (Table 1). As we have previously shown [4, 5] in
creased expression of NaPi-2 protein in K-deficient rats.parallel uptake measurements, there were no significant
Brush-border membrane proteins also were probedchanges in BBM Na/glucose or Na/proline cotransport
with a polyclonal antibody against type I Na/Pi cotrans-activities (results not shown).
port protein (NaPi-1). Once again, the decrease in BBM
Effects of chronic potassium deficiency on BBM Na/Pi Na/Pi cotransport activity in K-deficient rats was associ-
cotransport kinetics ated with a significant increase in BBM NaPi-1 protein
abundance (Table 1), which was documented by immu-Kinetic studies varying the extravesicular Pi concen-
nohistochemistry as well (results not shown). Finally, thetration revealed that the decrease in BBM Na/Pi cotrans-
BBM proteins were probed with a polyclonal antibodyport activity in K depletion was caused by a significant
against the type III Na/Pi cotransport protein (Glvr-1)decrease in the transport maximum (Vmax) of Na/Pi cotrans-
[46]. In K-deficient rats, there was also a significant up-port. There was no significant change in the affinity (Km)
regulation of the renal cortical Glvr-1 protein abundancefor Pi (Fig. 1). Similar studies varying the extravesicular
(Table 1).Na concentration revealed no change in the Km for Na.
Effects of chronic potassium deficiency on renal corticalEffects of chronic potassium deficiency on BBM
NaPi-2 mRNA abundance and mRNA-inducedNaPi-2, NaPi-1 and Glvr-1 protein abundance
oocyte Na/Pi cotransport activityThe next series of studies examined whether the de-
We next determined whether the decrease in BBMcrease in BBM Na/Pi cotransport activity in K-deficient
rats was mediated by a decrease in BBM type II Na/Pi Na/Pi cotransport activity in K-deficient rats was associ-
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Fig. 2. Effect of K deficiency (KD) on proxi-
mal tubular NaPi-2 protein expression, as de-
termined by confocal immunofluorescence
microscopy. The NaPi-2 protein is stained with
FITC-labeled secondary antibody. In spite of a
marked decrease in Na/Pi cotransport activity,
KD is associated with an increase in proximal
tubular apical BBM NaPi-2 protein expression.
ated with a decrease in renal cortical NaPi-2 mRNA control rats was injected into Xenopus laevis oocytes,
and the induced Na/Pi cotransport activity measured.abundance. Northern blotting of RNA from the renal
cortex with full-length NaPi-2 cDNA probe revealed no No difference in the induced Na/Pi cotransport activity
by mRNA from K-deficient versus control rats was foundchange in NaPi-2 mRNA abundance in K-deficient rats
when compared with control rats (Table 1). This was (Fig. 3), and there was no significant difference in Na/
leucine cotransport activity. However, as we have re-true even when the mRNA signal was normalized to 18 S.
mRNA isolated from the renal cortex of K-deficient and cently reported [5], there was a significant decrease in
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plays an important role in the modulation of Na/Pi co-
transport activity [24]. To determine whether the increase
in glucosylceramide content also modulated Na/Pi co-
transport in K-deficient rats, control and K-deficient rats
were treated with the glucosylceramide synthase inhibi-
tor PDMP. As previously demonstrated in dexametha-
sone-treated rats [24], PDMP caused significant decreases
in renal cortical homogenate and BBM glucosylceramide
content in control as well as in K-deficient rats (results
not shown). Treatment with PDMP caused significant
increases in BBM Na/Pi cotransport activity in both con-
trol rats and in K-deficient rats. In fact, the resultant
BBM Na/Pi cotransport activity in K-deficient rats was
identical to the Na/Pi cotransport activity in control rats
(Table 2). The effect of PDMP to increase and in factFig. 3. Effect mRNA isolated from control and K-deficient rat renal
normalize BBM Na/Pi cotransport activity in K-deficientcortex on oocyte Na/Pi cotransport activity. There was no difference
in the induced Na/Pi cotransport activity, indicating that changes in rats occurred independent of changes in BBM NaPi-2
mRNA levels or activity do not mediate the decrease in Na/Pi cotrans- protein or renal cortical NaPi-2 mRNA abundance (Ta-port activity in K deficiency.
ble 2).
DISCUSSIONNa/Si cotransport activity that correlated with the de-
creases in BBM Na/Si cotransport, BBM NaSi-1 protein Hypokalemia and/or potassium deficiency have been
and renal cortical NaSi-1 mRNA abundance. reported to be associated with decreases in serum Pi
concentration and increases in the urinary Pi excretionEffects of chronic potassium deficiency on BBM lipid
and Pi depletion [6–21]. Studies examining the cellularcomposition and lipid fluidity
mechanisms in the regulation of renal phosphate trans-
Since the decrease in BBM Na/Pi cotransport activity port in K deficiency, however, have been lacking. We
in K-deficient rats occurred independently of changes in used a model of dietary K deficiency in the rats that was
BBM NaPi-2 protein abundance, we questioned whether previously shown to be associated with an increase in
there were alterations in lipid composition and lipid flu- BBM Na/citrate [4] and a decrease in BBM Na/Si co-
idity that could potentially modulate BBM Na/Pi cotrans- transport activities [5]. Our study shows that K deficiency
port activity in K-deficient rats. After determining that results in a significant increase in urinary phosphate ex-
BBM lipid fluidity was significantly decreased in K-defi- cretion and a parallel decrease in BBM Na/Pi cotransport
cient rats, as shown by the increases in the fluorescence activity; also, the decrease in BBM Na/Pi cotransport
anisotropy of DPH and the generalized polarization of activity is mediated by a decrease in the Vmax of Na/PiLaurdan (Fig. 4), there were significant alterations in
cotransport. In previous studies in adaptation to alter-BBM phospholipid and glycosphingolipid composition.
ations in dietary Pi [40, 44], parathyroid hormone admin-In K-deficient rats, there was a significant decrease in
istration [45, 48], metabolic acidosis [49], aging [50], glu-BBM phosphatidylcholine content and a significant in-
cocorticoids [24], thyroid hormone [51], and epidermalcrease in BBM sphingomyelin content, resulting in a
growth factor [52], we have shown that the alterationssignificant increase in BBM sphingomyelin to phosphati-
in the Vmax of Na/Pi cotransport activity are associateddylcholine mole ratio (Fig. 5); additionally, in these rats
with parallel changes in BBM type II Na/Pi cotransportthere were significant increases in the renal cortical ho-
protein (NaPi-2) abundance as determined by Westernmogenate as well as BBM glucosylceramide and ganglio-
blotting and/or immunofluorescence microscopy. Inter-side GM3 content (Fig. 6). Other researchers as well as
estingly, the current study shows that the decrease inour group have shown previously that these lipid compo-
the Vmax of BBM Na/Pi cotransport activity was actuallysitional changes are associated with changes in BBM
associated with an increase in BBM NaPi-2 protein abun-lipid fluidity and modulation of BBM Na/Pi cotransport
dance. These effects were not due simply to differencesactivity [24, 31, 32, 47].
in the quality or purity of the BBM preparation, as the
Role of increased glucosylceramide content in increase in the abundance of the type II Na/Pi cotrans-
modulating Na/Pi cotransport activity in port protein was determined both by Western blotting
potassium-deficient rats and immunofluorescence microscopy. Double staining
for actin and NaPi-2 by immunofluorescence microscopyIn dexamethasone-treated rats, we have previously
shown that the increase in glucosylceramide content further documented that in K deficiency, the increased
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Fig. 4. Effect of K deficiency (KD) on BBM
lipid fluidity as determined by the (A) fluo-
rescence polarization (P) of 1,6-diphenyl-1, 3,
5-hexatriene (DPH) and (B) generalized po-
larization (GP) of Laurdan. Increases in PDPH
and GPLaurdan indicate that K deficiency causes
a decrease in lipid fluidity.
Fig. 5. Effect of K deficiency (KD) on BBM
phospholipid composition. K deficiency causes
an increase in sphingomyelin and a decrease
in phosphatidylcholine mole content.
Fig. 6. Effect of K deficiency (KD) on BBM
glycosphingolipid composition. K deficiency
causes an increase in glucosylceramide and
ganglioside GM3 content.
Table 2. Effects of DL-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol (PDMP) in control (Con) and potassium-deficient (KD) rats
Con KD Con  PDMP KD  PDMP
BBM Na/Pi cotransport activity pmol/5 s/mg BBM protein 87555 69259a 112054c 111648d
BBM NaPi-2 protein abundance densitometry units 3.60.4 10.51.2b 4.80.4c 10.40.8e
Renal cortical NaPi-2/18S mRNA abundance densitometry units 0.980.12 0.840.09 0.990.08 0.900.12
a P  0.05 compared to control
b P  0.001 compared to control
c P  0.05 compared to control
d P  0.01 compared to KD
e P  0.01 compared to control  PDMP
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abundance of NaPi-2 protein was localized to the apical
membrane of the proximal tubule. Most interestingly,
the decrease in Na/Pi cotransport activity and the in-
crease in NaPi-2 protein abundance were associated with
no change in renal cortical NaPi-2 mRNA abundance.
Furthermore, when mRNA isolated from control and
K-deficient rats were injected into oocytes, there were
no differences in the resultant Na/Pi cotransport activity.
These findings suggest that there is either a post-transla-
tional modification of the Na/Pi cotransport protein or
that K deficiency may modulate Na/Pi cotransport activ-
Fig. 7. Simplified outline of glycosphingolipid synthetic pathways. Inity through modulation of another Na/Pi cotransport
K deficiency, both sphingomyelin and glucosylceramide levels are in-protein. creased. PDMP is an inhibitor of glucosylceramide synthesis.
Recent studies using Npt2 knockout mice have dem-
onstrated that 85% of proximal tubular Na/Pi cotrans-
port activity is mediated by the type II Na/Pi cotransport
protein [53]. Furthermore, mice deficient in the type II Although alterations in lipid fluidity and/or lipid com-
position do modulate the activity of the existing Na/PiNa/Pi cotransport protein are not able to adapt to a low
Pi diet and develop significant hypophosphatemia and cotransporters, it is still not clear why there is actually
an increase in the number of Na/Pi cotransporters. Inter-phosphaturia, in spite of adaptive increases in the expres-
sion of NaPi-1 and Glvr-1 protein [54]. Indeed, the estingly, K deficiency has been shown to inhibit clathrin-
mediated endocytosis [62–66]. Although the mechanismsamounts of type I Na/Pi cotransport protein (NaPi-1),
and type III Na/Pi cotransport protein (Glvr-1) were that mediate the endocytosis of the Na/Pi cotransport
protein have not been fully elucidated, a recent immuno-increased significantly. Therefore, these results suggest
that in K-deficient rats the decrease in BBM Na/Pi co- gold microscopy study showed that, in response to para-
thyroid hormone-induced endocytosis of the type IItransport activity most likely is mediated through post-
translational mechanisms that modify the activity of the Na/Pi protein, the Na/Pi protein was localized in clathrin-
coated vesicles [67]. It is therefore possible that K defi-type II Na/Pi cotransport proteins, the most abundant
and physiologically most important Na/Pi cotransport ciency may cause inhibition of endocytosis of the type
II Na/Pi cotransport protein, resulting in an increasedprotein in the proximal tubule.
Potential post-translational mechanisms that we have BBM expression of this protein. Interestingly, in osteo-
blasts, acute depletion of cell K has been shown to induceidentified include a decrease in BBM fluidity and increases
in BBM sphingomyelin, glucosylceramide, and ganglio- an increase in Na/Pi cotransport activity [68]. However,
at this time, the cellular mechanisms of how K deficiencyside GM3 content. In previous studies, these lipid alter-
ations have been shown to cause alterations in lipid causes an increase in the brush-border membrane local-
ization of all the three types of Na/Pi cotransporter pro-fluidity and lipid dynamics [55–57] and to modulate intes-
tinal membrane Na/H exchange activity [58, 59]. In addi- teins remain unknown.
In our model of chronic K deficiency, the increases intion, we have shown that perturbations in lipid fluidity
and/or lipid composition (cholesterol, sphingomyelin, BBM sphingomyelin, glucosylceramide, and/or ganglio-
side GM3 content and the decrease in BBM fluidity ulti-and/or glucosylceramide) also modulate BBM Na/Pi co-
transport activity [24, 37, 36, 47]. The mechanisms of mately impair the activity of the BBM Na/Pi cotransport-
ers, resulting in a decrease in BBM Na/Pi cotransporthow changes in lipid fluidity and/or lipid composition
modulate Na/Pi cotransport activity are not known, but activity and an increase in urinary phosphate excretion.
Indeed, when K-deficient rats were treated with PDMP,may include physical effects on the protein, including
alterations in lateral or rotational mobility. In addition, an inhibitor of glucosylceramide synthase, there was a
significant increase (in fact normalization of BBM Na/Piwe have recently provided evidence for the presence
of lipid microdomains or lipid rafts in BBM that are cotransport activity) in the absence of further changes
in BBM NaPi-2 protein abundance.modulated further by changes in membrane lipid compo-
sition [37]. The marked changes in BBM sphingomyelin The mechanisms of how K deficiency causes parallel
increases in BBM sphingomyelin and glucosylceramideand ganglioside lipid composition would be expected
to further modulate the expression of lipid rafts and content are not known (Fig. 7 for a simplified outline of
sphingomyelin and glucosylceramide synthesis), but maymicrodomains, which may in turn regulate the activity
of the Na/Pi cotransport proteins [60, 61]. Furthermore, include hormonal mechanisms as well as alterations in
cell metabolism that result in the enhanced synthesis ofthe possibility exists that also there may be some direct
chemical modification of the protein by the lipids. both sphingomyelin and glucosylceramide [69–71]. In fact,
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